Metabolism News and Research

Latest Metabolism News and Research

Association between fitness and survival suggests a link between impaired oxygen metabolism and disease

Research published in the current issue of Science magazine reinforces the belief that aerobic capacity is an important determinant in the continuum between health and disease.

26 Jan 2005

Calcium boost to youths' bones could reduce osteoporosis risk

New research on calcium and bone development suggests that efforts to prevent osteoporosis, generally considered a geriatric disease among women, could actually start before puberty.

26 Jan 2005

Breakthrough in identifying causes and treatment for degenerative neurological diseases

A new, high resolution x-ray scanning technique that can look inside a single brain tissue cell, is a major step forward in identifying the role of iron and other metals in degenerative neurological diseases such as Alzheimer’s and Parkinson’s.

24 Jan 2005

Over-eating at an early age may stay well into adulthood

Melbourne researchers have found that over-eating at a very young age can have a long-lasting effect on the body and in particular seems to enhance the production of hormones made in fat and involved in metabolism.

24 Jan 2005

Insight into potential mechanisms underlying type II diabetes

New research published in the premier issue of Cell Metabolism finds that a single brain region is sufficient for normal control of blood sugar and activity level by the fat hormone leptin. The same region also exerts significant, though more modest, control over leptin's effects on body weight.

19 Jan 2005

Cellular fuel gauge could hold clue to diabetes

A molecule in the body could hold the key to explaining why people who exercise regularly are less likely to have illnesses such as type 2 diabetes.

19 Jan 2005

Scientists identify fat gene

UCLA/VA scientists have identified a new gene that controls how the body produces and uses fat. Called lipin, the gene may provide a new target for therapies to control obesity, diabetes and other weight-related disorders. The first issue of the new journal Cell Metabolism publishes the findings in its January 2005 edition.

19 Jan 2005

Home HIV-AIDS test could be a reality within two years

A portable device similar to a home pregnancy test that can quickly detect the presence of infectious diseases, including HIV-AIDS and measles as well as biological agents such as Ricin and anthrax, is the goal of a new joint research project

17 Jan 2005

Scientists uncover new evidence to help explain statins’ effects in Alzheimer’s disease

Scientists at Jefferson Medical College and the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia have taken another step in understanding the potential effects of anti-cholesterol drugs on Alzheimer’s disease.

12 Jan 2005

Euro funding for diabetes and exercise research

Researchers at The University of Nottingham are among a network of European scientists who have been awarded €12.7 million (around £8.7 million) for a study into the relationship between lack of exercise and the development of diabetes — and the health benefits of regular exercise in its prevention and cure.

12 Jan 2005

Molecular Devices introduces fatty acid uptake assay to target metabolic diseases

Molecular Devices Corporation announced the launch of its QBT Fatty Acid Uptake Assay Kit, the first assay kit that addresses the need for a single-step, homogenous in vitro assay for fatty acid uptake for use in high- throughput screening and metabolic disease research.

12 Jan 2005

Lack of sleep could make you fat

Lack of sleep could make you fat. In an editorial published in the Jan. 10 issue of the Archives of Internal Medicine, two Northwestern University researchers stress the need to better understand the growing epidemic of obesity in the United States by studying how loss of sleep alters the complex metabolic pathways that control appetite, food intake and energy expenditure.

10 Jan 2005

New portable infectious disease detector

A portable device similar to today's home pregnancy tests that can quickly detect the presence of infectious diseases, including HIV-AIDS and measles, as well as biological agents such as ricin and anthrax, is the object of a new joint university/industry research project.

10 Jan 2005

Girls' diets call for more calcium

Mother Nature's best efforts to protect growing bones come up short when girls' diets contain too little calcium, according to a study at the USDA Children's Nutrition Research Center at Baylor College of Medicine in Houston.

10 Jan 2005

Calcium intake contributing factor in formation of kidney stones

Individuals with either calcium oxalate or calcium phosphate kidney stones should not take extra calcium on their own as suggested by previous research, but should check with their doctors to determine the dietary guidelines that work best for them, researchers at UT Southwestern Medical Center at Dallas have found.

4 Jan 2005

Link between body-mass index and oral-contraceptive failure

Overweight and obese women who take oral contraceptives are 60 percent to 70 percent more likely to get pregnant while on the birth-control pill, respectively, than women of lower weight, according to new findings from Fred Hutchinson Cancer Research Center that will be published in the January issue of Obstetrics & Gynecology.

30 Dec 2004

Spinal cord injury and obesity

Researchers at the University of Michigan Health System are looking at how people with spinal cord injury burn calories and how that is affected by their muscle mass and body weight. The goal is to make better recommendations to people with spinal cord injury, but the research will also translate into greater understanding of obesity in the general population as well.

26 Dec 2004

Australia leads the way in new screening technology for babies

Australia is one of the first countries in the world to implement new screening technology across all States that will help detect an increased number of diseases in newborns.

21 Dec 2004

Obesity drug codenamed AOD9604 highly successful in trials

An Australian-owned obesity drug, developed by Melbourne-based biotechnology company Metabolic Pharmaceuticals Limited, is set to enter final human trials next year after successfully completing a Phase 2b human trial which proved that the drug induces weight loss and is very well tolerated with no evidence of the side effects commonly experienced with existing obesity drugs.

16 Dec 2004

Successful human trial of obesity drug that mimicks metabolic effects of growth hormone

The AOD9604 molecule is a small orally active peptide modelled on one section of the human growth hormone molecule. Growth hormone naturally occurs in the body and has profound stimulatory effects on fat metabolism, with levels of the hormone typically becoming suppressed in the obese state.

13 Dec 2004